MENU
SCTX Scribe Therapeutics Inc Forecast, Technical & Fundamental Analysis
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines... Show more
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I. Advisor
published Earnings
SCTX is expected to report earnings to fall 89.06% to -41 cents per share on December 02
Q3'26
Est.
$-0.42
Q2'26
Beat
by $2.36
The last earnings report on September 02 showed earnings per share of -383 cents, beating the estimate of -619 cents. With 12.80K shares outstanding, the current market capitalization sits at 297.23M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PIT | 78.31 | 0.55 | +0.71% |
| VanEck Commodity Strategy ETF (PIT) | |||
| BILT | 28.34 | 0.03 | +0.12% |
| iShares Infrastructure Active ETF (BILT) | |||
| IBHL | 24.39 | -0.11 | -0.45% |
| iShares iBonds 2032 Term High Yield and Income ETF (IBHL) | |||
| XSD | 455.96 | -5.09 | -1.10% |
| State Street SPDR S&P Semiconductor ETF (XSD) | |||
| SUIL | 5.84 | -0.52 | -8.22% |
| Volatility Shares 2x Sui ETF (SUIL) | |||
Related Blogs
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
1150 Marina Village Parkway
Phone
+1 510 626-8587
Employees
89
Web
https://www.scribetx.com